Lymphangioma medical therapy

	Lymphangioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Lymphangioma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Lymphangioma medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Lymphangioma medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Lymphangioma medical therapy
CDC on Lymphangioma medical therapy
Lymphangioma medical therapy in the news
Blogs on Lymphangioma medical therapy
Directions to Hospitals Treating Lymphangioma
Risk calculators and risk factors for Lymphangioma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2] Haytham Allaham, M.D. [3]

Overview

There is no particular medical treatment for lymphangioma. The mainstay of therapy is surgery.

There is no particular medical treatment for lymphangioma. The mainstay of therapy is surgery:

However, propranolol is a potential option, which can be used in intractable lymphangiomatosis.^[1]
Sodium tetradecyl sulfate is an off-label option for treatment of lymphangioma circumscriptum.^[2]

Other therapies include:^[3]

Destructive treatments with carbon dioxide (CO2) laser
Long-pulsed Nd-YAG laser
Electrosurgery
Cryotherapy
Superficial radiotherapy sclerotherapy with 23.4% hypertonic saline
Direct injection of a sclerosing agent, including 1% or 3% sodium tetradecyl sulfate, doxycycline or ethanol

↑ Sack M, Cassidy JT, Bole GG, Vinar O (December 1975). "Prognostic factors in polyarteritis". J. Rheumatol. 2 (4): 411–20. PMID 1533.
↑ Moos F, Richard P, Sugiura M, Iwasaki K, Kato R (November 1975). "[Adrenergic and cholinergic control of oxytocin release evoked by vaginal, vagal and mammary stimulation in lactating rats (author's transl)]". J. Physiol. (Paris) (in French). 70 (3): 315–32. PMID 1524.
↑ Rajasingham R, Bell JL, Baron DN (1971). "A comparative study of the isoenzymes of mammalian alpha-amylase". Enzyme. 12 (2): 180–6. PMID 5556746.